Market Overview:
The global pharmaceutical outsourcing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for generic drugs, rising prevalence of chronic diseases, and growing number of contract research organizations (CROs). In addition, the increasing focus on cost-effective drug development and manufacturing is also contributing to the growth of this market. The raw material sourcing segment is expected to account for the largest share in terms of revenue in 2018. This can be attributed to the growing demand for active pharmaceutical ingredients (APIs) and finished drugs from emerging markets such as Asia Pacific and Latin America.
Product Definition:
Pharmaceutical outsourcing is the contracting out of specific drug-manufacturing processes, such as active pharmaceutical ingredient production, to a third party. The practice has grown in recent years as drugmakers seek to cut costs and improve efficiency. Pharmaceutical outsourcing can also include the manufacturing of finished drugs and other services such as marketing and distribution.
Raw Material Sourcing:
Raw material sourcing is the process of procuring materials to make products or services. In pharmaceutical industry, raw materials are used to manufacture drugs and other healthcare products. Pharmaceutical companies source raw materials from numerous suppliers located across the globe in order to produce a wide range of finished dosage forms as well as bulk drug substances for different therapeutic areas such as oncology, neurology, cardiology and others.
Active Pharmaceutical Ingredient:
Active pharmaceutical ingredient (API) is the most important raw material used in the production of drugs. It is also known as a active ingredient, which is generally derived from natural sources such as plants and animals. The API acts as an essential component for drug development and formulates. Pharmaceutical outsourcing companies are engaged in providing API services to ensure that drug developers have access to sufficient quantities of high-quality APIs for their clinical trials on time and within budget.
Application Insights:
Drug discovery and clinical trials accounted for the largest share in 2015. Outsourcing of drug discovery and clinical trials is considered as an effective method to reduce costs while accelerating the pace of new drug development. The key players in this market are adopting various methods, such as direct contract research, sub-contract research with manufacturers, or collaboration with biopharmaceutical companies for developing novel drugs.
The preclinical development segment is expected to witness lucrative growth over the forecast period owing to increasing R&D expenditure by key players on a contract basis. For instance, in September 2016 Pfizer Inc., one of the U.S.-based multinational pharmaceutical company entered into a partnership with Allergan plc., an Irish biotechnology firm for discovering potential medicines using cellular models through its proprietary program known as Translational Research Program - Cell Based (TRP-C).
Regional Analysis:
Asia Pacific is expected to be the fastest-growing region over the forecast period owing to factors such as increasing R&D activities, rising healthcare spending by countries like China and India. In addition, growing outsourcing opportunities in emerging Asian countries are expected to drive regional market growth. The Asia Pacific pharmaceutical outsourcing market was valued at USD X billion in 2017 and is estimated to grow at a CAGR of XX% from 2018 to 2030.
The Latin American pharmaceutical outsourcing market is also anticipated have significant growth potential due its low cost structure compared with developed regions such as North America and Europe which makes it attractive for clinical trials & drug development organizations (DDO)to outsource their manufacturing needs in this region thereby driving the overall LSO industry growth rate positively over the forecast period.
Growth Factors:
- Increasing demand for generic drugs due to patent expirations of blockbuster drugs.
- Rising incidence of chronic diseases such3. Growing demand for specialty and orphan drugs4. Increasing focus on cost containment by healthcare payers5. Proliferation of contract research organizations and drug discovery services providers
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical outsourcing Market Research Report
By Type
Raw Material Sourcing, Active Pharmaceutical Ingredient, Finished Drugs
By Application
Drug Discovery, Clinical Trials, Pre-Clinical Development, Biology Research
By Companies
ABC Laboratories, Aenova, Alkermes, Associates of Cape Cod, BioPharma Solutions, Catalent Pharma Solutions, Coldstream Laboratories, Covance, Cytovance Biologics, Dalton Pharma Services, DPT Laboratories, Emergent BioSolutions, Fresenius Kabi, Grand River Aseptic Manufacturing, Halo Pharmaceutical, IGI Laboratories, Lyophilization Technology, Metrics, Mikart, Patheon, Pillar5 Pharma, Velesco Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical outsourcing Market Report Segments:
The global Pharmaceutical outsourcing market is segmented on the basis of:
Types
Raw Material Sourcing, Active Pharmaceutical Ingredient, Finished Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Discovery, Clinical Trials, Pre-Clinical Development, Biology Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ABC Laboratories
- Aenova
- Alkermes
- Associates of Cape Cod
- BioPharma Solutions
- Catalent Pharma Solutions
- Coldstream Laboratories
- Covance
- Cytovance Biologics
- Dalton Pharma Services
- DPT Laboratories
- Emergent BioSolutions
- Fresenius Kabi
- Grand River Aseptic Manufacturing
- Halo Pharmaceutical
- IGI Laboratories
- Lyophilization Technology
- Metrics
- Mikart
- Patheon
- Pillar5 Pharma
- Velesco Pharma
Highlights of The Pharmaceutical outsourcing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Raw Material Sourcing
- Active Pharmaceutical Ingredient
- Finished Drugs
- By Application:
- Drug Discovery
- Clinical Trials
- Pre-Clinical Development
- Biology Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical outsourcing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical outsourcing is the process of contracting with a third-party company to provide pharmaceuticals and related services. Outsourcing can help companies save money by reducing the need to maintain their own pharmaceutical manufacturing or R&D capabilities.
Some of the major players in the pharmaceutical outsourcing market are ABC Laboratories, Aenova, Alkermes, Associates of Cape Cod, BioPharma Solutions, Catalent Pharma Solutions, Coldstream Laboratories, Covance, Cytovance Biologics, Dalton Pharma Services, DPT Laboratories, Emergent BioSolutions, Fresenius Kabi, Grand River Aseptic Manufacturing, Halo Pharmaceutical, IGI Laboratories, Lyophilization Technology, Metrics, Mikart, Patheon, Pillar5 Pharma, Velesco Pharma.
The pharmaceutical outsourcing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical outsourcing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical outsourcing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical outsourcing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical outsourcing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical outsourcing Market Size & Forecast, 2020-2028
4.5.1 Pharmaceutical outsourcing Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical outsourcing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Raw Material Sourcing
5.2.2 Active Pharmaceutical Ingredient
5.2.3 Finished Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Drug Discovery
6.2.2 Clinical Trials
6.2.3 Pre-Clinical Development
6.2.4 Biology Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical outsourcing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical outsourcing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Raw Material Sourcing
9.6.2 Active Pharmaceutical Ingredient
9.6.3 Finished Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Drug Discovery
9.10.2 Clinical Trials
9.10.3 Pre-Clinical Development
9.10.4 Biology Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Raw Material Sourcing
10.6.2 Active Pharmaceutical Ingredient
10.6.3 Finished Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Drug Discovery
10.10.2 Clinical Trials
10.10.3 Pre-Clinical Development
10.10.4 Biology Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Raw Material Sourcing
11.6.2 Active Pharmaceutical Ingredient
11.6.3 Finished Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Drug Discovery
11.10.2 Clinical Trials
11.10.3 Pre-Clinical Development
11.10.4 Biology Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Raw Material Sourcing
12.6.2 Active Pharmaceutical Ingredient
12.6.3 Finished Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Drug Discovery
12.10.2 Clinical Trials
12.10.3 Pre-Clinical Development
12.10.4 Biology Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Raw Material Sourcing
13.6.2 Active Pharmaceutical Ingredient
13.6.3 Finished Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Drug Discovery
13.10.2 Clinical Trials
13.10.3 Pre-Clinical Development
13.10.4 Biology Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical outsourcing Market: Competitive Dashboard
14.2 Global Pharmaceutical outsourcing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ABC Laboratories
14.3.2 Aenova
14.3.3 Alkermes
14.3.4 Associates of Cape Cod
14.3.5 BioPharma Solutions
14.3.6 Catalent Pharma Solutions
14.3.7 Coldstream Laboratories
14.3.8 Covance
14.3.9 Cytovance Biologics
14.3.10 Dalton Pharma Services
14.3.11 DPT Laboratories
14.3.12 Emergent BioSolutions
14.3.13 Fresenius Kabi
14.3.14 Grand River Aseptic Manufacturing
14.3.15 Halo Pharmaceutical
14.3.16 IGI Laboratories
14.3.17 Lyophilization Technology
14.3.18 Metrics
14.3.19 Mikart
14.3.20 Patheon
14.3.21 Pillar5 Pharma
14.3.22 Velesco Pharma
